Limited systemic absorption of intraperitoneal ceftizoxime in a patient with Serratia marcescens peritonitis.
Grabe
D W
DW
Albany College of Pharmacy, New York, USA.
Bailie
G R
GR
Eisele
G
G
Venezia
R
R
D015296:Ceftizoxime / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D016868:Serratia Infections / Q000188:drug therapy* / Q000209:etiology; D012706:Serratia marcescens
D002511:Cephalosporins; D015296:Ceftizoxime